Physician profile
Douglas Olson
NPI 1811289846
$4,036.34
in general payments reported to CMS, 2019-2025
10 companies · $2,150 in 2025
The $2,150 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,363 · 2020: $54.04 · 2021: $56.40 · 2022: $138 · 2023: $24.61 · 2024: $251 · 2025: $2,150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,461 · Food and Beverage: $888 · Education: $77.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,460.57 |
| Food and Beverage | $887.91 |
| Education | $77.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,513.22 | 2019-2025 | Oxford, Tapestry, Juggerloc |
| Cdc Medical LLC | $1,035.00 | 2019 | |
| Stryker Corporation | $169.91 | 2019-2025 | Pangea |
| Smith+Nephew, INC. | $99.64 | 2020-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Heron Therapeutics, INC. | $83.92 | 2025 | Zynrelef |
| Integra Lifesciences Corporation | $37.60 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $33.11 | 2024 | Durolane |
| Breg, INC | $27.20 | 2021 | |
| Solventum Corporation | $19.76 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Ethicon US, LLC | $16.98 | 2025 | Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.